Mobilization of Bone Marrow-Derived Progenitors
Bone marrow (BM) is a source of various stem and progenitor cells in the adult, and it is able to regenerate a variety of tissues following transplantation. In the 1970s the first BM stem cells identified were hematopoietic stem cells (HSCs). HSCs have the potential to differentiate into all myeloid (including erythroid) and lymphoid cell lineages in vitro and reconstitute the entire hematopoietic and immune systems following transplantation in vivo. More recently, nonhematopoietic stem and progenitor cells have been identified that can differentiate into other cell types such as endothelial progenitor cells (EPCs), contributing to the neovascularization of tumors as well as ischemic tissues, and mesenchymal stem cells (MSCs), which are able to differentiate into many cells of ectodermal, endodermal, and mesodermal origins in vitro as well as in vivo. Following adequate stimulation, stem and progenitor cells can be forced out of the BM to circulate into the peripheral blood, a phenomenon called “mobilization.” This chapter reviews the molecular mechanisms behind mobilization and how these have led to the various strategies employed to mobilize BM-derived stem and progenitor cells in experimental and clinical settings. Mobilization of HSCs will be reviewed first, as it has been best-explored—being used extensively in clinics to transplant large numbers of HSCs to rescue cancer patients requiring hematopoietic reconstitution—and provides a paradigm that can be generalized to the mobilization of other types of BM-derived stem and progenitor cells in order to repair other tissues.
KeywordsMobilization Hematopoietic stem cells Endothelial progenitor cells Mesenchymal stem cells Transplantation Tissue repair
Unable to display preview. Download preview PDF.
- de Haan G, Ausema A, Wilkens M, et al (2000) Efficient mobilization of haematopoietic progenitors after a single injection of pegylated recombinant human granulocyte colony-stimulating factor in mouse strains with distinct marrow-cell pool sizes. Br J Haematol 110:638–646PubMedCrossRefGoogle Scholar
- King AG, Horowitz D, Dillon SB, et al (2001) Rapid mobilization of murine hematopoietic stem cells with enhanced engraftment properties and evaluation of hematopoietic progenitor cell mobilization in rhesus monkeys by a single injection of SB-251353, a specific truncated form of the human CXC chemokine GRObeta. Blood 97:1534–1542PubMedCrossRefGoogle Scholar
- Lévesque JP, Winkler IG, Sims N, et al (2005) The inhibition of the osteoblast niche during hematopoietic stem cell mobilization is an indirect effect involving mature bone marrow leukocytes, IL6 and soluble IL6 receptor. Blood 106:557a [abstract]Google Scholar
- Minatoguchi S, Takemura G, Chen XH, et al (2004) Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment. Circulation 109:2572–2580PubMedCrossRefGoogle Scholar
- Nilsson SK, Haylock DN, Johnston HM, et al (2003) Hyaluronan is synthesized by primitive hemopoietic cells, participates in their lodgment at the endosteum following transplantation, and is involved in the regulation of their proliferation and differentiation in vitro. Blood 101:856–862PubMedCrossRefGoogle Scholar
- To LB, Bashford J, Durrant S, et al (2003) Successful mobilization of peripheral blood stem cells after addition of ancestim (stem cell factor) in patients who had failed a prior mobilization with filgrastim (granulocyte colony-stimulating factor) alone or with chemotherapy plus filgrastim. Bone Marrow Transplant 31:371–378PubMedCrossRefGoogle Scholar
- Torii Y, Nitta Y, Akahori H, et al (1998) Mobilization of primitive haemopoietic progenitor cells and stem cells with long-term repopulating ability into peripheral blood in mice by pegylated recombinant human megakaryocyte growth and development factor. Br J Haematol 103:1172–1180PubMedCrossRefGoogle Scholar